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ABSTRACT 
 
In this research, the PLA/PLGA scaffolds and films were prepared successfully from 
PLA/PLGA blank microparticles. The morphology of the PLA/PLGA scaffolds and films are 
characterized by means of SEM. Biodegradable and biocompatible scaffolds having a highly 
open porous structure and good mechanical strength are needed for cell proliferation, 
migration, and differentiation, and guidance for cellular in-growth. Biodegradable porous 
scaffolds can be surface engineered to provide an optical microenvironment for better cell 
adhesion and tissue in-growth. According to scanning electron microscopy (SEM), a 3-
dimensional porous structure of films could be observed on the surface. As the morphology 
of PLA/PLGA scaffolds and films could not be stabilized, we investigated the effect of 
temperature and concentration of polymer on the properties of microporous scaffolds and 
films. The degradation of polymeric porous films occurs through a homogeneous hydrolytic 
chain cleavage mechanism and this process is altered by factors such as molecular weight and 
molecular weight distribution. So, the biocompatible film plays an important role in 
development of fully biodegradable, tissue compatible active wound dressing material. 
Keywords: scaffold; microporous film; PLA; PLGA 
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1. INTRODUCTION 
Scaffolds are key components in the tissue engineering paradigm, in which they can 
function as templates to allow new tissue growth and provide temporary structural support. 
The development of novel scaffolds is very challenging and critical to achieve the appropriate 
function for tissue regeneration (Kretlow, 2007). Biodegradable and biocompatible 
nanocomposite micro particles are developed as cell scaffolds. 
Scaffolds play a critical role in tissue engineering. The regulation of the growth of 
cells either cultivated within the porous structure of the scaffold or migrating from 
surrounding tissue is one of the major functions of the scaffold. Generally mammalian cells 
are anchorage-dependent.  So, the scaffold gives a suitable substrate for cell attachment, cell 
proliferation, differentiated function and cell migration. The physicochemical properties of 
scaffolds are: to support and deliver cells; induce, differentiate, and channel tissue growth; 
target cell-adhesion substrates; stimulate cellular response. These are biocompatible and 
biodegradable; highly porous with a large surface/volume ratio; possess mechanical strength 
and dimensional stability; and have sterilisability. Generally, three-dimensional porous 
scaffolds can be fabricated from natural and synthetic polymers. 
To achieve the goal of tissue reformation, scaffolds must face some specific 
requirements. A high porosity and an appropriate pore size are necessary to facilitate cell 
seeding and diffusion throughout the whole structure of both cells and nutrients. The degree 
of biodegradability is an essential factor, since scaffolds should preferably be absorbed by the 
surrounding tissues without the necessity of a surgical removal. The rate at which degradation 
occurs has to coincide as much as possible with the rate of tissue formation: this means that 
while cells are fabricating their own natural matrix structure around themselves, the scaffold 
must provide the structural integrity within the body and eventually it will break down 
leaving the new tissue, newly formed tissue which will take over the mechanical load. 
Tissue engineering has emerged as a promising alternative approach to treat the loss 
or malfunction of a tissue or organ without the limitations of current therapies (Langer et al., 
1993) Tissue engineering involves the expansion of cells, followed by the culturing of the 
cells in temporary three-dimensional scaffolds to form the new organ or tissue. 
Therefore, porous three-dimensional temporary scaffolds play an important role in 
manipulating cell function and regulation of new organ formation (Peter et al., 1995). Isolated 
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and expanded cells adhere to the temporary scaffold in all three dimensions, generally 
proliferate, and secrete their own extracellular matrices, replacing the biodegrading scaffold. 
Significant challenges to this approach include the design and manufacture of the scaffolds. 
Ideally, scaffolds for tissue engineering should meet several design criteria: (1) the surface 
should permit cell adhesion, promote cell growth, and allow the retention of differentiated 
cell functions; (2) the scaffolds should be biocompatible; (3) the scaffold should be 
biodegradable and eventually eliminated; (4) the porosity should be high enough to provide 
sufficient space for cell adhesion, extracellular matrix regeneration and the porous structure 
of scaffold must allow even spatial cell distribution throughout the scaffold to facilitate 
homogeneous tissue formation; (5) the material should be reproducibly able to process into 
three-dimensional structure, and should be mechanically strong. 
Many processing techniques have been developed to fabricate natural and synthetic 
polymeric scaffolds. Although naturally derived materials are more versatile in providing 
various biological functions, synthetic polymeric scaffolds are favoured because they can be 
fabricated from a wide range of biodegradable polymers with easy process ability, controlled 
degradation, and susceptibility to modification (Peter et al., 1998). While natural polymeric 
scaffolds are generally fabricated by freeze drying/cross linking in aqueous solution, 
synthetic polymeric scaffolds have been prepared by various methods including solvent 
casting, particulate leaching, phase separation, (Mikos et al., 1993). The surfaces of a scaffold    
promote cell adhesion by specific cell– matrix interactions (Hubbell et al., 1995). 
Furthermore, growth factors can be encapsulated or imbedded within the porous matrices and 
delivered in a sustained manner to enhance cell growth and morphogenesis. 
Studies on scaffolds releasing DNA encoding the growth factor have also been 
suggested as an alternative approach to bypass limitations of protein delivery (Park et al., 
2001). Recently, 3-D matrices based on different structural characteristics or minimally 
invasive surgical methods have drawn attention for potential tissue engineering applications 
in the next generation. A nanofibrous matrix prepared by electro spinning or self-assembly 
would provide a better resemblance of the physiological environment (Fig. 1-B) (Boyan et 
al., 1999). Hydrogels (Fig. 1-C) and micro-spheres (Fig. 1-D), which are already widely 
utilized as sustained protein release formulations, have also been applied in tissue 
engineering for its potential use as a cell delivery carrier or supportive matrix (Hutmacher et 
al., 2001). This review will introduce previous techniques for fabricating biodegradable 
scaffolds, followed by surface engineered and drug releasing scaffolds for directing a series 
of tissue regeneration processes in a more active manner. 
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Fig. 1 Different forms of polymeric scaffolds for tissue engineering: (A) a typical 3-D porous 
matrix in the form of a solid foam, (B) a nanofibrousmatrix, (C) a thermo sensitive Sol–gel 
transition hydro gel and (D) porous microsphere. 
 
Many biodegradable types of polymers, such as PLA and PLGA, often used in 
clinical applications for a very long time. There are several methods for the preparation of 
porous, biodegradable film has been developed in the past few years. The method of solvent–
nonsolvent (SNS) phase separation is one of the most convenient route to prepare 
multiporous films with micro pores on the surface, and these structures enhance the 
hydrophilicity of the films. 
Polymers, which are manufactured or processed to be suitable for use in or as a 
medical device. Recently, a variety of polymers, biopolymers have been developed 
specifically for medical applications. 
Polymeric wound dressings that are capable of maintaining a controlled environment 
at the wound site have been shown to promote healing (Winter, et al; 1962). Active wound 
dressings have been developed to promote healing that enable the controlled, local delivery of 
therapeutic agents (Higa et al., 1999). 
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Ideally, the active wound dressing would deliver a nearly instantaneous initial dosage of the 
drug at the optimum therapeutic concentration, followed by a sustained constant delivery rate 
of the drug that maintains the local concentration at the optimum dosage level for as many 
days as necessary to achieve complete and effective wound healing. 
In this study, to obtain a novel film structure for wound healing, we investigated the 
factors that could affect the micro forming of PLA and PLGA film with micro porous 
structure.   
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2. REVIEW OF LITERATURE 
Polymer materials have received increasing attention and been widely used for tissue 
engineering because of easy control over biodegradability and process ability. There are two 
kinds of polymer materials: synthetic polymer, and naturally derived polymers (Thomson, et 
al; 1995). The main biodegradable synthetic polymers include polyesters, such as poly 
(glycolic acid) (PGA), poly (lactic acid) (PLA), and their copolymer of poly [lactic-co-
(glycolic acid)] (PLGA) are most commonly used for tissue engineering. PLA undergoes 
hydrolytic scission to its monomeric form, lactic acid, which is eliminated from the body by 
incorporation into TCA cycle. The major elimination path for lactic acid is respiration, and it 
is primarily excreted by lungs as CO2. PGA can be broken down by hydrolysis, nonspecific 
esterases and carboxypeptidases.  
PLA (poly lactic acid) and PLGA (poly lactic acid/glycolic acid) are superior in 
biocompatibility and biodegradability, and also act as base material for sustained-release 
formulation.   
2.1 PLA 
The name "polylactic acid" is to be used with caution, not complying to standard 
nomenclatures (such as IUPAC) and potentially leading to ambiguity (PLA is not a poly acid 
(polyelectrolyte), but rather a polyester. 
 
Fig. 2 Chemical structure of PLA  
Poly (lactide) (PLA) has been widely used in various biomedical applications due to 
its biodegradability, biocompatibility, and good mechanical properties. The processing of this 
material by conventional means (such as film casting and foaming) often imposes several 
limitations in the optimization of their final properties. 
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Synthesis 
 
 
Fig. 3 Catalytic and thermolytic ring-opening polymerization of lactide (left) to polylactide 
(right) 
Bacterial fermentation is used to produce lactic acid from corn starch or cane sugar.But lactic 
acid cannot be directly polymerized to a useful product, because each polymerization reaction 
produces one molecule of water, which accelerates the degradation of the forming polymer 
chain. Dimerization also generates water; which can be separated prior to polymerization due 
to a wide variation in polarity. High molecular weight PLA is generated from the delectate 
ester by ring-opening polymerization , but for laboratory demonstrations tin (II) chloride is 
often used.  
Chemical and physical properties 
Due to the chiral nature of lactic acid, several unique forms of poly lactide exist: poly-
L-lactide (PLLA) is the product resulting from polymerization of L,L-lactide (also known as 
L-lactide). The degree of crystallinity of PLLA is around 37%, having a glass transition 
temperature between 60-65 °C, a melting temperature between 173-178 °C and a tensile 
modulus between 2.7-16 GPa (John et al., 2000). However, heat resistant PLA can withstand 
temperatures of 110C (230F).  
PLA has similar mechanical properties to polymer PETE, but has a significantly lower 
maximum continuous use temperature. 
Polylactic acid can be processed like most thermoplastics into fibre (for example 
using conventional melt spinning processes) and film. The melting temperature of PLLA can 
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be increased 40-50 °C and its heat deflection temperature can be increased from 
approximately 60°C to up to 190 °C by physically blending the polymer with PDLA (poly-D-
lactide). A highly regular stereo complex with increased crystallinity is produced by PDLA 
and PLLA. The temperature stability is maximised when a 50:50 blend is used, but even at 
lower concentrations of PDLA, there is still a substantial improvement. In the latter case, 
PDLA acts as a nucleating agent, as a result the crystallization rate is increasing. 
Biodegradation of PDLA is slower than for PLA due to the higher crystallinity of PDLA. 
PDLA has the useful property of being optically transparent. There is also poly (L-lactide-co-
D,L-lactide) (PLDLLA) – used as PLDLLA/TCP scaffolds for bone engineering.  
2.2. PLA SCAFFOLD 
Bioresorbable scaffolds of polylactic acid (PLA) offer several benefits. They require 
only a single surgery and leave native tissue behind. They gradually transfer load to tissue 
during the degradation period, useful for bone remodelling and reducing the risk of re-
fracture. They can be also used to drugs delivery, growth factors or other substances 
conducive to the healing of bone locally to the implant site (Middleton, 2000). 
The acidic products from the degradation of PLA act to catalyse further degradation 
which can cause an accumulation of acidic products at the healing site and elicit an 
inflammatory response. Hydroxyapatite (HA) is known to buffer the acidic degradation 
products of polylactic acid. Addition of HA to scaffolds results in controlled rate of 
degradation and reduced risk of inflammation. Exposure of osteogenic cells to bioactive 
ceramics such as HA is known to increase osteoblast differentiation and growth (Jung et al., 
2005). 
Biodegradable synthetic polymers including poly (lactic acid) (PLA) are suitable for 
biocompatible scaffold constructs but are known to undergo in vitro degradation. This may 
limit their potential for use in long-term cultures or loading regimes. This investigation 
determines whether it is advantageous to culture cells on scaffolds prior to mechanical 
compression 
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Figure.4 SEM photomicrographs of cross sections of PLA scaffolds prepared with the 
weight fractions of ice particulates of 70% (a), 80% (b), and 90% (c). 
PLA is biodegradable thermoplastic polyester that can be produced through ring-
opening polymerization of lactic acid. Since lactic acid is a chiral molecule, it exists in two 
forms, D-PLA and LPLA. PLLA is the result of L-PLA polymerization. While PLLA is 
semi-crystalline and it shows a high mechanical strength, poly (D,L-lactic acid) (PLA) is 
essentially amorphous, or, at most with a low crystallinity. 
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The methylated version of PGA is PLA ,but is less hydrophilic and, therefore, it degrades 
slowly.Poly (lactic acid) PLLA degrades to form lactic acid which is normally present in the 
body. This acid then enters TCA cycle and is excreted as water and carbon dioxide. 
2.3 PLGA 
PLGA or poly(lactic-co-glycolic acid) is a copolymer which is used in a host of Food 
and Drug Administration (FDA) approved therapeutic devices, due to its biodegradability and 
biocompatibility.  
 
Fig.5 Chemical structure of PLGA 
PLGA is synthesized by means of random ring-opening co-polymerization of two 
different monomers, the cyclic dimers (1, 4-dioxane-2,5-diones) of glycolic acid and lactic 
acid. In the preparation of this polymer common catalysts used are  tin(II) 2-ethylhexanoate, 
tin(II) alkoxides, or aluminium isopropoxide.  Monomeric units (of glycolic or lactic acid) are 
linked together in PLGA by ester linkages during polymerization, thus yielding a linear 
aliphatic polyester as a product. 
PLGA is soluble in wide range of common solvents including chlorinated solvents, 
tetrahydofuran, acetone or ethyl acetate. Degradation of PLGA occurs in water by hydrolysis 
of its ester linkages. Presence of methyl side groups in PLA makes it more hydrophobic than 
PGA and hence lactide rich PLGA copolymers have low degree of hydrophilicity, absorb less 
water and more slowly degraded. Due to the hydrolysis of PLGA, parameters that are 
typically considered invariant descriptions of a solid formulation  change with time, such as 
moisture content, molecular weight and the glass transition temperature (Tg). 
The change in PLGA properties during polymer biodegradation influences the release 
and degradation rates of incorporated drug molecules. PLGA physical properties themselves 
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have been shown to depend upon multiple factors, including the initial molecular weight, the 
size of the device, exposure to water and storage temperature. 
Different forms of PLGA can be obtained depending on the ratio of lactide to 
glycolide used for the polymerization. These are usually identified in regard to the monomers' 
ratio used (e.g. PLGA 75:25 identifies a copolymer whose composition is 75% lactic acid and 
25% glycolic acid). All PLGAs are amorphous rather than crystalline and show a glass 
transition temperature in the range of 40-60 °C. PLGA can be dissolved by a wide range of 
common solvents, including chlorinated solvents, tetrahydrofuran, acetone or ethyl acetate. 
PLGA degrades by hydrolysis of its ester linkages in water. It has been observed that 
the time required for degradation of PLGA is related to the monomers' ratio used in 
production: the higher the content of glycolide units, less time required for degradation. An 
exception to this rule is the copolymer with 50:50 monomers' ratio which exhibits the faster 
degradation. The end-capped  polymers with esters (as opposed to the free carboxylic acid) 
demonstrate longer degradation half-lives. 
PLGA has been successful as a biodegradable polymer because it undergoes 
hydrolysis in the body as a result of which original monomers are produced, lactic acid and 
glycolic acid.  Under normal physiological conditions these two monomers are by-products 
of various metabolic pathways in the body. As the body effectively deals with the two 
monomers, there is minimal toxicity associated with using PLGA for drug delivery or 
biomaterial applications. Also, the possibility to tailor the polymer degradation time by 
altering the ratio of the monomers used during synthesis has made PLGA a common choice 
in the production of a variety of biomedical devices like implants, prosthetic devices, micro 
and nanoparticles, grafts and sutures. 
2.4. PLGA SCAFFOLD 
PLGA and its copolymers are the most extensively used for biodegradable and 
biocompatible scaffolds. These polymers which are biocompatible, biodegradable are 
approved by the Food and Drug Administration (FDA), and are easily processed into various 
3-D matrices like structures. 
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Especially, biodegradable devices made of poly (lactide-co-glycolide) (PLGA) 
copolymers are advantageous due to their controlled degradation behaviour and tunable 
mechanical properties. The rate of polymer degradation should be carefully controlled to 
synchronize with the rate of tissue formation and in-growth to achieve successful 
regeneration or repair within a desired time frame. 
A variety of techniques have been used for processing biodegradable polymers into   
3-D porous scaffolds. The conventional methods include fibre felts, fibre bonding, melt 
moulding, solvent casting/particulate leaching, phase separation method, and processing of 
high pressure. A number of 3-D porous scaffolds fabricated from various kinds of 
biodegradable materials have been developed and used for tissue engineering of liver (Kneser 
et al.,1999), bladder (Oberpenning et al.,1999), nerve (Hadlock et al., 2000), skin ( 
Hansbroughbone et al., 1993), cartilage (Cao et al.,1997) and ligament( Freed et al., 1994) 
etc. 
The fabrication of three-dimensional (3D) scaffolds that mimic the cellular 
microenvironment is of fundamental importance to the success of tissue engineered 
constructs. Both scaffold chemistry and architecture can influence the fate and function of 
engrafted cells (Bhatia et al., 1999).  
Material microstructure, in contrast, is often controlled by process parameters such as 
the choice of solvent in phase separation, gas foaming, woven fibres, and controlled ice 
crystal formation and subsequent freeze-drying to create pores (Lo H et al., 1995) however, 
these scaffolds lack a well-defined organization that is found in most tissues. 
Modification of the bulk properties of the porous poly (lactide-co-glycolide) (PLGA) 
scaffold was performed by irradiation with a high energy cyclotron proton ion beam. The 
PLGA scaffolds were formulated in advance by the gas-foaming method by employing 
ammonium bicarbonate particles as porogens. 
Irradiation with ion beams was performed with 40 MeV for 3, 6 and 9 min on the 
scaffolds at a distance of 30 cm from the beam exit to the scaffold surface. The bulky ion 
beam-treated PLGA scaffold apparently demonstrated no color changes. The chemical 
structures of the untreated samples seemed to be kept well when analyzed by both Fourier 
transformed infrared but a subtle change was observed in its x-ray photoelectron 
spectroscopy.  
The results of in vitro tissue culture with smooth muscle cells for up to 4 weeks also 
demonstrated no significant difference in terms of its handling stability during cell culture 
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and cellular behaviour between the untreated PLGA scaffolds and the ion beam-treated 
PLGA scaffolds. However, significant changes were observed in its molecular weight as 
measured by gel permeation chromatography, indicating a significant molecular weight 
reduction. These results of in vitro tests and GPC measurements indicated that while bulk 
modification of the scaffold was processed (Woo et al., 2009). 
Scaffolding plays an important role in tissue engineering. In this work, a novel 
processing technique has been developed to create three-dimensional biodegradable polymer 
scaffolds with well-controlled interconnected pores which are spherical in nature. Paraffin 
spheres were fabricated with a dispersion method, and were bonded together strongly through 
a heat treatment to form a three-dimensional mold structure. Biodegradable polymers such as 
PLLA and PLGA were dissolved in a solvent and cast onto the paraffin sphere assembly. 
After dissolving the paraffin, a porous polymer scaffold was formed. The fabrication 
parameters have importance in relation to the pore shape, interpore connectivity, pore wall 
morphology, and mechanical properties of the polymer scaffolds. The modulus of the 
scaffolds decreased with increasing porosity. More time for heat treatment of the paraffin 
spheres resulted in larger openings between the pores of the scaffolds. Foams of smaller pore 
size (100-200 micron) resulted in significantly lower compressive modulus than that of larger 
pore sizes (250-350 or 420-500 micron). The PLLGA foams had a skeletal structure 
consisting of small platelets, whereas homogeneous skeletal structures were found in PLGA 
foams. The new processing technique can make the polymer scaffolds for a variety of 
potential tissue engineering applications because of the well-controlled architecture, interpore 
connectivity, and mechanical properties (Ma PX et al., 2001) 
Solvent-evaporation method was modified using sucrose as an additive to form large 
porous microparticle of poly (d,l-lactic-co-glycolic) (PLGA)  polymer. Micro particles 
containing hydrophilic polymers (poly vinyl alcohol) incorporated in their internal matrix 
structure were also formulated. Different formulations of micro particles were evaluated for 
physical properties, cell adhesion, and cell growth in culture. PLGA micro particles 
containing poly(vinyl alcohol) (PVA) in the matrix structure (PLGA-PVA) and treated with 
serum prior to cell seeding demonstrated better cell adhesion and cell growth than other 
formulations of micro particles. (Labhasetwar et al., 2005). 
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3. OBJECTIVES 
1. Preparation of blank PLA and PLGA micro particles 
2. Preparation of PLA and PLGA Scaffolds 
3. Preparation of PLA and PLGA Films 
4. Characterization of PLA and PLGA Scaffolds and Films by SEM 
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4. MATERIALS AND METHODS 
4.1. Preparation of PLA and PLGA micro particles 
4.1.1.: Equipments  
 Stratos low-temperature high-speed centrifuge(Thermo, Germany) 
 Cooling centrifuge (REMI) 
 Magnetic stirrer 
 Sonicator  
 Scanning electron microscope (Jeol Jsm-6480 LV) 
 
4.1.2. Materials required: 
 Sucrose 
 PLA(Sigma- Aldrich) 
 DCM 
 PVA(Sigma- Aldrich) 
4.1.3. Procedure: 
PLA and PLGA dummy particles were prepared using double solvent evaporation method. 
Method is as follows: 
1) Internal aqueous phase (200 micro litres):10% sucrose (w/v) 
2) Organic phase (4 ml)                                 : PLA 200mg/4 ml DCM 
                                                                       : PLGA 200mg/4 ml DCM 
3) External aqueous phase (16 ml)               :1% PVA (w/v) 
                                                                       : 10% Sucrose (w/v)  
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4.1.4. Preparation: 
 Polymer dissolved in organic phase (4 ml) was associated with 200 micro litre 
of internal aq.phase was added to make primary emulsion. 
 For the formation of the secondary emulsion 16ml of external aq.phase was 
taken in a beaker and the primary emulsion was added drop wise while 
sonicating the primary emulsion. This led to the formation of the secondary 
emulsion.  
 This was kept on a magnetic stirrer for overnight for excess DCM to evaporate. 
Particles formed were separated by centrifugation at 15000 RPM which was 
performed for a period of 20 minutes. 
 Separated particles were washed twice with ice cold MQ water. After washing 
the particles were lyophilized for 24 hrs to obtain dry particles. 
 
4.2 Preparation of PLA /PLGA Scaffold 
For PLA and PLGA  
Chemicals required: 
 Chloroform 
 Ethanol 
 Ammonium bicarbonate 
 Aqueous citric acid 
Procedure: 
For both PLA and PLGA micro particle 
• 100 mg of PLA /PLGA micro particle dissolved in chloroform was precipitated in 
ethanol. 
• A gel slurry was obtained, 50 mg of ammonium bicarbonate salt particles mixed with 
this gel paste were cast in a mold, semi solidified at room temperature and immersed 
into 5 ml of aqueous citric acid solution. 
• Finally macro porous PLA/PLGA scaffolds with a porosity of over 90% were 
obtained.  
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Fig.6: PLA scaffold      Fig7: PLGA scaffold  
4.3. Preparation of PLA and PLGA films 
For PLA and PLGA 
Chemicals required: 
 Dichloro methane(DCM) 
 Tetrahydrofuran (THF) 
 Ethylene glycol(EG) 
 Glycerol 
Procedure:  
For both PLA and PLGA micro particle 
• 100 mg of PLA/PLGA microparticle was first dissolved in 5 ml of DCM at room 
temperature. 
• After PLA/PLGA microparticle was completely dissolved in 10 ml of THF was then 
added into the mixed solution at 55
0
C to ablate DCM by volatilization. 
• Since PLA/PLGA was uniformly dissolved in THF the solution was added dropwise 
onto the surface of EG/glycerol mixed solution. 
• Finally the system was left for volatilization overnight and was microporous 
PLA/PLGA film was obtained.  
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         Fig 8: PLA Film  
 
Fig 9: PLGA Film  
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5. RESULTS 
Characterization of PLA and PLGA scaffolds and films by SEM 
The PLA scaffold prepared by this method was highly porous with evenly distributed and 
interconnected pore structures. The pore shapes were almost the same as those of the ice 
particulates. The degree of interconnection increased as the weight fraction of the ice 
particulates increased.  
 
 
 
                Fig.10 SEM images of PLA scaffolds 
The polymer concentration also had some effect on the pore wall structure, i. e., lower 
polymer concentration resulted in more porous pore wall structures. The porosity and surface 
area/weight ratio increased with the increase of the weight fraction of the ice particulates. 
Therefore, the pore structure of the porous temporary scaffolds could be manipulated by 
varying the shape, weight fraction, size of the ice particulates, and the polymer concentration. 
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Fig. 11 PLGA microspheres                               Fig .12 PLGA scaffold with pores 
 
The wettability of a polymer scaffold is considered very important for homogeneous 
structure. Under the fabrication conditions used here, the PLGA microspheres have a 
spherical morphology with a smooth surface. 
 
 
 
Fig .13 SEM morphology of various types of PLA porous films at different temperatures 
The morphology observation shown in above indicates that the pore appearances in 
different films are conspicuously different and that the films had a smoother surface .The 
pores are evenly distributed throughout the film.  
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The volatility of THF at different temperatures was not concordant, and for this 
reason, we obtained various PLA films with disparate morphology. We observed the scaffold 
prepared at 4°C, 25°C and 50°C, the film had unique micro pores on its surface. This 
experiment showed an ambient temperature is beneficial for shaping the surface of the 
scaffold with multipores and the obtained films were smoother at a low speed of phase 
separation. That is to say, a moderate rate of evaporation is beneficial for formation of 
droplets of the solvent, and after these droplets volatilized, spherical holes appeared and 
occupied the interface. 
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6. CONCLUSION 
 
In this study, the morphology of PLA/PLGA scaffolds and films prepared from 
PLA/PLGA blank microparticle are observed. The results showed that PLA /PLGA scaffolds 
possessed higher degree of porosity with evenly distributed and interconnected pore 
structures. The pore shapes were almost the same as those of the ice particulates. The 
polymer concentration also had some effect on the pore wall structure, i.e., lower polymer 
concentration resulted in more porous pore wall structures. These porous scaffolds prepared 
by solvent casting/particulate leaching have been intensively studied to provide implantable 
devices for tissue regeneration. These polymeric devices are usually surface modified by 
immobilizing cell adhesive or growth factor binding moieties to improve its cell adhesive 
characteristics or actively induce cell migration, proliferation and differentiation. According 
to SEM films had a smoother surface and the pores are evenly distributed throughout the 
film. The degradation of PLA and PLGA microfilms occurs through a homogeneous 
hydrolytic chain cleavage mechanism where the rates of polymer degradation are similar for 
both the surface and the bulk of the microfilms. Factors such as molecular weight and 
molecular weight distribution as well as sterilization may also alter the degradation rate of the 
biodegradable polyesters in microfilms. In these way biocompatible films represents an 
important advance in the development of fully biodegradable, tissue compatible active wound 
dressing material capable of delivering a broad range of therapeutic agents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
7. REFERENCES 
 
B. D. Boyan, C. H. Lohmann, J. Romero, Z. Schwartz, Clin. Plast. Surg. 1999, 26,629. 
Bhatia SN, Chen CS. Tissue engineering at the micro-scale. Biomed Microdevices 
1999;2(2):131–44. 
D. W. Hutmacher, J. Biomater. Sci., Polym. Ed. 2001, 12,107. 
F. Oberpenning, J. Meng, J. J. Yoo, A. Atala, Nat. Biotechnol.1999, 17, 149. 
Hadlock T, Sundback C, Hunter D, Cheney M, Vacanti JP. A polymer foam conduit seeded 
with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng 
2000;6(2):119–27. 
Higa O, Rogero S, Machado L, Mathor M, Lugao A. Biocompatibility study for PVP J. A. 
Hubbell, Biotechnology (N. Y.) 1995, 13, 565. 
J. F. Hansbrough, J. L. Morgan, G. E. Greenleaf, R. Bartel, J. Burn Care Rehabil. 1993, 14, 
485. 
Jung Y., Kim S.-S., Young H.K., Kim S.-H., Kim B.-S., Kim S., Cha Y.C., Soo H.K. A 
poly(lactic acid)/calcium metaphosphate composite for bone tissue engineering. 
Biomaterials. 2005;26(32):6314 .Kretlow, J.D., Advanced Drug Delivery Reviews, 
2007. 59(4-5):263-273. 
Kretlow, J.D., Advanced Drug Delivery Reviews, 2007. 59(4-5):263-273. 
L.E. Freed, G. Vunjak-Novakovic, R.J. Biron, D.B. Eagles, D.C. Lesnoy, S.K. Barlow, R. 
Langer, Biodegradable polymer scaffolds for tissue engineering, Nat. Biotechnol. 12 
(1994) 689–693. 
Lo H, Ponticiello MS, Leong KW. Fabrication of controlled release biodegradable foams by 
phase separation. Tissue Eng1995;1:15–28. 
Ma PX,Choi JW,2001, Department of Biologic and Material Sciences, Macromolecular 
Science and Engineering Center, University of Michigan, Ann Arbor, Michigan 
48109-1078. 
Middleton J.C., Tipton A.J. Synthetic biodegradable polymers as orthopedic devices. 
Biomaterials. 2000;21(23):2335. 
Mikos AG, Lyman MD, Freed LE, Langer R. Wetting of poly(l-lactic acid) and poly(dl-
lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994;15:55–8. 
R. C. Thomson, M. J. Yaszemski, J. M. Powers, A. G. Mikos, J. Biomater. Sci., Polymer. 
Edn. 1995, 7, 23. 
 
23 
S. J. Peter, M. J. Miller, A. W. Yasko, M. J. Yaszemski, A.G. Mikos, J. Biomed. Mater. Res. 
1998, 43,422. 
 S. L. Ishaug, G. M. Crane, M. J. Miller, A. W. Yasko, M. J.Yaszemski, A. G. Mikos, J. 
Biomed. Mater. Res. 1997, 36,17. 
T. Hadlock, C. Sundback, D. Hunter, M. Cheney, J. P.Vacanti, Tissue Eng. 2000, 6, 119. 
U. Kneser, P. M. Kaufmann, H. C. Fiegel, J. M. Pollok, D.Kluth, H. Herbst, X. Rogiers, J. 
Biomed. Mater. Res. 1999,47, 494. wound dressing obtained in different conditions. 
Radiat Phys Chem 1999; 55:705-707. 
Y. Cao, J. P. Vacanti, K. T. Paige, J. Upton, C. A. Vacanti,Plast. Reconstr. Surg. 1997, 100, 
297. 
 
             
